"We will continue to focus on a range of issues in relation to the PBS, of course, and important internal matters like governance, the Code of Conduct and listening to the membership - but our industry is also on the cusp of something quite extraordinary," says Vifor Pharma's James McDonnell.
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep .24
July 17, 2026 - - Podcast -
Ex-Novartis leader joins the board of emerging nuclear medicine company
July 17, 2026 - - Latest News -
It doesn't always feel like it, but make no mistake, this is what winning looks like
July 17, 2026 - - Latest News -
Telix opens Australia's first integrated radiopharmaceutical facility in Melbourne
July 16, 2026 - - Latest News

